Genetic findings in a Turkish clinical cohort with hereditary Parkinson’s disease
Neurogenetics · 2026
DOI: 10.1007/s10048-026-00949-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurogenetics, 2026. Verfasst von Dilek Ozata Aksoy und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, University of Health Sciences, Ankara, Türk…. Hauptthemen laut MEDLINE: Parkinson Disease, Ubiquitin-Protein Ligases. Die Arbeit nennt 51 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: Parkinson's disease (PD) is a multifactorial neurodegenerative disorder driven by a complex interplay of genetic and environmental factors. This study aimed to characterize the mutational spectrum in a cohort of patients with clinically suspected hereditary PD using complementary genetic testing approaches. MATERIALS AND METHODS: A total of 36 patients underwent genetic evaluation. Targeted next-generation sequencing (NGS) of a 10-gene PD panel was performed in 35 patients, Multiplex ligation-dependent probe amplification (MLPA)-based copy-number analysis using an 8-gene panel was conducted in 9 patients, and targeted Sanger sequencing was performed in one patient with a known familial PRKN variant. RESULTS: The most clinically relevant findings involved the PRKN gene. A homozygous pathogenic variant in the PRKN gene was detected in 3 patients, compound heterozygous deletions involving the PRKN and PACRG genes in one patient, and a single heterozygous PRKN variant classified as pathogenic was detected in one patient. Additionally, variants of uncertain significance were identified in 7 patients in the ATP13A2, PRKN, VPS35, PINK1, and PLA2G6 genes. CONCLUSION: Using complementary molecular genetic techniques, we identified clinically relevant genetic findings in a cohort of 36 patients with suspected hereditary Parkinson's disease. These findings provide population-specific data on the mutational spectrum of PD in a Turkish clinical cohort and contribute to the characterization of the regional genetic landscape.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Genetics, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, University of Health Sciences, Ankara, Türkiye. dilekozata25@gmail.com.
- Department of Medical Genetics, Gulhane Faculty of Medicine, University of Health Sciences, Ankara, Türkiye.
- Department of Neurology, Gulhane Faculty of Medicine, University of Health Sciences, Ankara, Türkiye.
- Department of Neurology, Ataturk Sanatoryum Training and Research Hospital, University of Health Sciences, Ankara, Türkiye.
Zitieren
APA
Ozata Aksoy, D., Tunca, Y., Sonkaya, A. R., Torun, D., & Korucu, O. (2026). Genetic findings in a Turkish clinical cohort with hereditary Parkinson’s disease. Neurogenetics. https://doi.org/10.1007/s10048-026-00949-5
Vancouver
Ozata Aksoy D, Tunca Y, Sonkaya AR, Torun D, Korucu O. Genetic findings in a Turkish clinical cohort with hereditary Parkinson’s disease. Neurogenetics. 2026. doi:10.1007/s10048-026-00949-5
BibTeX
@article{OzataAksoy2026,
author = {Ozata Aksoy, Dilek and Tunca, Yusuf and Sonkaya, Ali Riza and Torun, Deniz and Korucu, Osman},
title = {Genetic findings in a Turkish clinical cohort with hereditary Parkinson’s disease},
journal = {Neurogenetics},
year = {2026},
doi = {10.1007/s10048-026-00949-5}
}
EUVIMED